| Welcome to Finance Insider, Business Insider's summary of the top stories of the past 24 hours. Sign up here to get the best of Business Insider delivered direct to your inbox. There's a $60 billion bidding war brewing for Shire, the maker of ADHD medications like Adderall. Shire has already rejected an offer of that amount from Japan's Takeda. Shire said in a statement that Takeda's $60 billion bid "continues to significantly undervalue the company and Shire's growth prospects and pipeline." Allergan then confirmed it was "in the early stages of considering a possible offer" for Shire. That sent Allergan's stock price plummeting, falling more than 8%. CNBC then reported Thursday afternoon that Allergan would not make a bid for Shire, with Allergan's share price rebounding. What a wild ride. Elsewhere in healthcare news, a leaked video shows Theranos employees playing the video game they created where you shoot at the reporter who exposed the startup's problems. In markets news: Lastly, a trader named Morgan Stanley left Morgan Stanley and now someone is selling his business cards for $1 million. | 
Tidak ada komentar:
Posting Komentar